Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs Gemcitabine-Oxaliplatin in Pancreatic Cancer
NCT00075452Phase 3Unknown
- Sponsor
- GERCOR
- Start
- Nov 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in pancreatic adenocarcinoma (PDAC), sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00075452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075452.